http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05194316-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee5dece8cd6ccb38a0350b77a83e5e98
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-24
filingDate 1992-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0086e9c6c8f8c15db5d85a1b9a1547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d275d01dd56c434be3eea3705dbb3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d68080d9117e7675a8d39fa49175cfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69221e3673921cb9433d175fed45401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f03b918ca176a4f5da73bfd92c3cd09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_157a7834c825b302fb272e91dba5a994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d32f36e0e0051961be418502a1fe9e9
publicationDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H05194316-A
titleOfInvention P-oxybenzoic acid derivative, method for producing the same, and hypolipidemic agent containing p-oxybenzoic acid derivative as an active ingredient
abstract (57) [Summary] [Object] To provide a p-oxybenzoic acid derivative which is particularly effective for hypolipidemic effect. [Structure] General formula (Where R 1 is the following formula: R 2 is the following formula: And a mixture of diastereomers and enantiomers or stereoisomers in its pure form and physiologically compatible salts thereof. It also relates to a method for producing the same and a hypolipidemic agent having a hypolipidemic effect.
priorityDate 1991-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9906793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396167
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100125140
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24377
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14381
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8266
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14380
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2539
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101453374
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234790931
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281179
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID107828938
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102594145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20510717

Total number of triples: 69.